Letrozole and semen/hormone measures in infertile men
Improved testosterone-to-estradiol ratio and changed semen parameters.
Small study; infertility context.
Original source ↗Loading TrenasCycles…
TrenasCycles
Loading TrenasCycles…
Ancillary / aromatase inhibitor
Femara
Letrozole is a strong estrogen-lowering drug that comes up in discussions of high estrogen and gyno. It reduces estrogen production rather than just blocking estrogen in breast tissue. Oversuppressing estrogen can leave joints sore and cause fatigue, hot flashes, worse cholesterol and bone loss.
FEMARA breast-cancer treatment in postmenopausal women. Liver impairment can change exposure and dosing; this is not a routine male or bodybuilding amount.
Small male trials show strong estradiol suppression and testosterone changes. Long-term benefit/risk for AAS users is not established.
Profound estradiol deficiency, bone loss, joint pain, adverse lipids, fatigue and sexual/mood effects.
Estradiol, symptoms, bone health and lipids under clinician care.
Approved for selected breast-cancer indications; male fertility/hypogonadism and AAS use are off-label.
Improved testosterone-to-estradiol ratio and changed semen parameters.
Small study; infertility context.
Original source ↗Letrozole strongly lowered estradiol and increased testosterone.
Only 28 days; no long-term safety conclusion.
Original source ↗